In Person Seminar: Cognitive Bias Modification in the Treatment of Addiction: Efficacy and New Insights into Working Mechanisms
Reinout Wiers, Ph.D.
Professor
Department of Psychopathology
University of Amsterdam
Pioneers in Biomedical Research Seminar: Cognitive Bias Modification in the Treatment of Addiction: Efficacy and New Insights into Working Mechanisms
About this Seminar
Varieties of Cognitive Bias Modification (CBM) have been developed and tested in addiction, with evidence of efficacy when added to the treatment of alcohol use disorders across clinical trials. Originally, these interventions were based on dual process models of addiction, with the assumption that CBM would impact associative (automatically activated cognitive-motivational) processes, while traditional therapy would impact reflective processes. However, basic research has undermined this perspective, leading to the development of a new propositional variety of CBM, ABC training (Wiers et al., 2020), which Dr. Wiers will describe and present first data on.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Addiction Recovery Research Center and the Center for Health Behaviors Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home ItemCANCELLED: In Person Seminar: Circadian Clocks in Skeletal Muscle; Contributions to Systemic Health , home
March 29, 2024, 11:00 a.m. | Karyn Esser, Ph.D., Professor and Chair, Physiology and Aging, University of Florida College of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemThe Impact of Climate Change on Vulnerable Populations: What Can Be Done? , home
April 4, 2024, 5:30 p.m. (Reception at 5 p.m.) | Zulfiqar Bhutta, Ph.D., Robert Harding Inaugural Chair in Global Child Health, Hospital for Sick Children, Professor, Department of Paediatrics, Nutritional Sciences and Public Health, University of Toronto | Maury Strauss Distinguished Public Lecture
-
Home ItemIn Person Seminar: The Meaning of Dopamine , home
April 5, 2024, 11:00 a.m. | Henry Yin, Ph.D., Professor, Psychology and Neuroscience, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home ItemWhat is Alzheimer's Disease and Can We Prevent It? , home
April 11, 2024, 5:30 p.m. (Reception at 5 p.m.) | Kristine Yaffe, M.D., Professor and Roy and Marie Scola Endowed Chair of Psychiatry, Neurology, and Epidemiology, Director, Center for Population Brain Health, University of California, San Francisco, Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemIn Person Seminar: Addiction Recovery: From Culture to Science , home
April 12, 2024, 11:00 a.m. | John Kelly, Ph.D., Elizabeth R. Spallin Professor of Psychiatry in Addiction Medicine, Harvard Medical School | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
-
Home ItemIn Person at CNRIC: Hyperactivation of an RNA Binding Protein by Cancer-associated Mutations , home
April 19, 11:00 a.m., Collaboratory, Children's National Research and Innovation Campus, Washington, D.C. | Daniel Dominguez, Ph.D., Assistant Professor, Pharmacology, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group